Máj- és epeúti rák: vizsgálatok itt: Egyesült Államok

In Egyesült Államok 301 Also abroad 1316

301 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.

2. fázisTaking people
Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)
Where
Pittsburgh, San Antonio
Életkor
18 év and over
People
40
Run by
Anwaar Saeed
See details and how to joinNCT06698250
1/2. fázisTaking people
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Where
Atlanta, Austin, Basking Ridge, Birmingham, Commack, Detroit, Durham, Fairfax, Grand Rapids, Hackensack, Harrison, Houston, Indianapolis, Irving, Lake Success, Lebanon, Long Island City, Los Angeles, Madison, Miami, Middletown, Montvale, New Brunswick, Oklahoma City, Orange, Saint Louis Park, Salt Lake City, San Antonio, Seattle, Uniondale, West Valley City
Életkor
18 év and over
People
150 worldwide
Run by
Astellas Pharma Global Development, Inc.
See details and how to joinNCT07488676
1. fázisNot yet taking people in Egyesült Államok
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Where
Bethesda
Életkor
18 év to 120 év
People
20
Run by
National Cancer Institute (NCI)
See details and how to joinNCT07715903
No phaseTaking people
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Where
Los Angeles
Életkor
18 év to 99 év
People
360
Run by
Cedars-Sinai Medical Center
See details and how to joinNCT04907643
2. fázisTaking people
Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy
Where
Houston
Életkor
18 év and over
People
140
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT04982653
No phaseTaking people
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
Where
Houston
Életkor
19 év and over
People
60
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT05053555
1. fázisTaking people
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Where
Atlanta, Austin, East Brunswick, Edmonds, Fairfax, Fort Worth, Grand Rapids, Houston, Lake Success, Nashville, New Brunswick, New Haven, San Antonio, Sioux Falls, St Louis, Washington D.C., West Valley City, Wilson
Életkor
18 év and over
People
124 worldwide
Run by
Pliant Therapeutics, Inc.
See details and how to joinNCT06270706
No phaseTaking people
TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma
Where
Ann Arbor, Bay City, Detroit, Flint, Houston, Lansing, Lapeer, Mount Pleasant
Életkor
22 év and over
People
198
Run by
Barbara Ann Karmanos Cancer Institute
See details and how to joinNCT07118202
1. fázisTaking people
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Where
Boston, Duarte, Houston, Newport Beach, New York
Életkor
16 év and over
People
171
Run by
SEED Therapeutics, Inc.
See details and how to joinNCT07197554
1. fázisTaking people
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Where
Boston, Fairfax, Houston, Los Angeles, Philadelphia, Salt Lake City, San Antonio, Sarasota, Tampa
Életkor
18 év and over
People
545
Run by
Kestrel Therapeutics, Inc.
See details and how to joinNCT07458347
1. fázisTaking people
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Where
Bethesda
Életkor
18 év to 120 év
People
30
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06066138
1/2. fázisTaking people
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Where
Ann Arbor, Baltimore, Boston, Charlottesville, Fairfax, Houston, Los Angeles, Nashville, New York, Philadelphia, Salt Lake City, Seattle, St Louis
Életkor
18 év and over
People
616 worldwide
Run by
Verastem, Inc.
See details and how to joinNCT07020221
2. fázisTaking people
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
Where
Atlanta, Boston, Irvine, Los Angeles, Orange, Peoria, Santa Monica
Életkor
18 év to 100 év
People
104 worldwide
Run by
CatalYm GmbH
See details and how to joinNCT07219459 · EU 2025-520675-86-00
No phaseNot yet taking people in Egyesült Államok
Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy
Where
Duarte
Életkor
18 év and over
People
70
Run by
City of Hope Medical Center
See details and how to joinNCT07608458
2. fázisNot yet taking people in Egyesült Államok
Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer
Where
Baltimore
Életkor
18 év and over
People
55
Run by
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT07793253
No phaseTaking people
Collection of Blood From Patients With Cancer
Where
Bethesda
Életkor
18 év and over
People
1750
Run by
National Cancer Institute (NCI)
See details and how to joinNCT00034216
No phaseTaking people
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Where
Bethesda
Életkor
18 év and over
People
750
Run by
National Cancer Institute (NCI)
See details and how to joinNCT00451022
2. fázisTaking people
A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
Where
Boston, Chicago, Houston, Jacksonville, New York, Phoenix, Rochester, Tampa
Életkor
18 év and over
People
30 worldwide
Run by
Elevar Therapeutics
See details and how to joinNCT07359820
2. fázisTaking people
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Where
Grand Forks, Jacksonville
Életkor
18 év and over
People
220
Run by
Mayo Clinic
See details and how to joinNCT05969860
No phaseTaking people
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Where
Allentown, Altamonte Springs, Austin, Baltimore, Boston, Celebration, Centerville, Chicago, Cleveland, Columbus, Detroit, Fort Myers, Fullerton, Gainesville, Los Angeles, Madison, Manhasset, Miami, Mission Viejo, Mobile, Newport Beach, New York, Reno, Richmond, Rochester, San Francisco, Santa Monica, Seattle, Shreveport, Winston-Salem, Wyoming
Életkor
22 év and over
People
5000
Run by
HistoSonics, Inc.
See details and how to joinNCT06486454
No phaseTaking people
The Vanguard Study: Testing a New Way to Screen for Cancer
Where
Bethesda, Brownstown, Chapel Hill, Charlottesville, Chesterfield, Cheyenne Wells, Cleveland, Clinton Township, Dearborn, Denver, Detroit, Durham, Fairfax, Fort Collins, Greeley, Grosse Pointe Farms, Honolulu, Kansas City, Lafayette, Livonia, Lone Tree, Loveland, Milwaukee, Minneapolis, Norfolk, Novi, Oklahoma City, Pleasanton, Plymouth, Portsmouth, Richmond, Royal Oak, San Diego, South Hill, Springfield, Sterling Heights, St Louis, Tacoma, Troy, West Bloomfield, Wyandotte
Életkor
45 év to 75 év
People
24 000
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06995898
No phaseTaking people
CREO - Microwave Ablation Feasibility Study
Where
Chicago, Gilbert, Houston, Knoxville, Los Angeles, Morgantown
Életkor
18 év and over
People
75
Run by
Banner Health
See details and how to joinNCT07817147
3. fázisTaking people
D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
Where
Cleveland, Dallas, Miami Beach, Tucson
Életkor
18 év and over
People
240 worldwide
Run by
InnoPharmax Inc.
See details and how to joinNCT06622057
2. fázisTaking people
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Where
Birmingham, Boston, Cleveland, Detroit, Duarte, Farmington Hills, Fort Myers, Houston, Madison, Nashville, Seattle
Életkor
18 év and over
People
111 worldwide
Run by
Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00
2. fázisNot yet taking people in Egyesült Államok
A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma
Where
Birmingham
Életkor
18 év and over
People
29
Run by
Mehmet Akce
See details and how to joinNCT06855225